HS
HighVista Strategies Portfolio holdings
AUM
$388M
1-Year Est. Return
180.25%
This Fund
S&P 500
1 Year Est. Return
+180.25%
AUM
$388M
AUM Growth
-$19.7M
(-4.8%)
Holding
181
Top Buys
| 1 | +$6.38M | |
| 2 | +$5.85M | |
| 3 | +$4.05M | |
| 4 |
Pharvaris
PHVS
|
+$3.91M |
| 5 |
Stoke Therapeutics
STOK
|
+$3.47M |
Top Sells
| 1 | +$12.9M | |
| 2 | +$12.6M | |
| 3 | +$12.3M | |
| 4 |
SNDK
Sandisk
SNDK
|
+$8.63M |
| 5 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$8.61M |
Sector Composition
| 1 | Healthcare | 69.79% |
| 2 | Technology | 6.85% |
| 3 | Industrials | 5.94% |
| 4 | Financials | 3.09% |
| 5 | Consumer Discretionary | 2.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Invesco DB Commodity Index Tracking Fund
DBC
$1.47B
| $23.6M | 6.09% |
1,057,238
-378,898
|
|
||
2
Structure Therapeutics
GPCR
$4.45B
| $13.4M | 3.46% |
193,001
-43,235
|
|
||
3
Cogent Biosciences
COGT
$6.04B
| $12M | 3.08% |
336,667
-125,738
|
|
||
4
Viridian Therapeutics
VRDN
$2.8B
| $11.6M | 2.99% |
372,472
-96,863
|
|
||
|
ABVX
5
Abivax
ABVX
$8.78B
| $9.73M | 2.51% |
72,185
-112,283
|
|
||
6
Revolution Medicines
RVMD
$19.4B
| $9.58M | 2.47% |
120,240
-55,208
|
|
||
7
Praxis Precision Medicines
PRAX
$8.83B
| $7.62M | 1.96% |
25,841
-69,161
|
|
||
8
Nuvalent
NUVL
$7.78B
| $7.37M | 1.9% |
73,287
-20,007
|
|
||
9
Cytokinetics
CYTK
$7.42B
| $7.28M | 1.87% |
114,564
-18,366
|
|
||
10
Terns Pharmaceuticals
TERN
$4.51B
| $7.09M | 1.83% |
+175,462
|
|
||
|
MAZE
11
Maze Therapeutics
MAZE
$2.13B
| $7.06M | 1.82% |
+170,353
|
|
||
12
Insmed
INSM
$31.4B
| $6.86M | 1.77% |
39,400
-10,549
|
|
||
13
Apogee Therapeutics
APGE
$4.68B
| $6.74M | 1.73% |
89,229
-17,878
|
|
||
14
Protagonist Therapeutics
PTGX
$5.71B
| $6.42M | 1.65% |
73,545
-48,137
|
|
||
15
Soleno Therapeutics
SLNO
$2.03B
| $6.25M | 1.61% |
135,069
+116,369
|
|
||
16
Spyre Therapeutics
SYRE
$3.15B
| $6.17M | 1.59% |
188,206
-27,540
|
|
||
17
BridgeBio Pharma
BBIO
$12.5B
| $6.13M | 1.58% |
80,205
-1,754
|
|
||
18
Olema Pharmaceuticals
OLMA
$1.88B
| $6.04M | 1.55% |
241,489
-195,690
|
|
||
19
Immunovant
IMVT
$5.44B
| $5.64M | 1.45% |
221,883
-31,244
|
|
||
20
Liquidia Corp
LQDA
$2.76B
| $5.38M | 1.39% |
156,003
-20,482
|
|
||
21
Vaxcyte
PCVX
$8.59B
| $5.26M | 1.36% |
114,049
+27,247
|
|
||
|
CDTX
22
DELISTED
Cidara Therapeutics
CDTX
| $5.06M | 1.3% |
22,928
-47,976
|
|
||
23
Arcellx
ACLX
$6.59B
| $4.89M | 1.26% |
75,002
-21,175
|
|
||
24
Relay Therapeutics
RLAY
$1.71B
| $4.61M | 1.19% |
545,079
+304,620
|
|
||
25
Rhythm Pharmaceuticals
RYTM
$5.98B
| $4.59M | 1.18% |
42,867
+5,385
|
|